Nasdaq · CIK 0001232524 · PHARMACEUTICAL PREPARATIONS
Jazz Pharmaceuticals plc
JAZZ chart by TradingView
PRICE HISTORY
LIVE · NASDAQJAZZ chart by TradingView
- REVENUE FY2025 ENDED DEC 2025
- $4.3B
- EBITDA
- $-0.4B
- FREE CASH FLOW
- $1.3B
- EPS
- $-5.84
- GROSS MARGIN
- —
- ROIC
- -4.30%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
17.8x
-14%12.1x424.3x
⤢
P / SALES (TTM)
3.6x
-31%1.6x6.2x
⤢
P / BOOK
3.5x
-15%1.7x4.5x
⤢
EV / EBITDA (TTM)
20.2x
+18%11.7x782.3x
⤢
EV / REVENUE (TTM)
4.2x
-35%2.6x7.1x
⤢
FCF YIELD (TTM)
9.52%
+2.6pp6.26%19.98%
⤢
DIVIDEND YIELD (TTM)
—
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$1.2B
+223%⤢
EBITDA (DERIVED)
$0.4B
+157%⤢
NET INCOME
$0.2B
+115%⤢
EPS (DILUTED)
$2.78
+91%⤢
REVENUE GROWTH YOY
15.55%
+5.8pp-0.46%39.48%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
32.91%
-2.0pp4.59%60.71%
⤢
RETURN ON CAPITAL
12.49%
+2.5pp-5.14%16.62%
⤢
RETURN ON EQUITY (TTM)
19.59%
-0.2pp-12.47%21.98%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN—
OPERATING MARGIN20.54%
NET MARGIN15.96%
FCF MARGIN32.91%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$0.4B
+204%⤢
STOCK-BASED COMP
$0.1B
+195%⤢
CAPITAL EXPENDITURE
$0.0B
+660%⤢
SHARES OUTSTANDING
0.07B
+12%⤢
DIVIDEND / SHARE
—
BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$1.6B
+342%⤢
TOTAL DEBT
$4.4B
+99%⤢
DEBT / EBITDA (TTM)
4.5x
+13%2.2x261.7x
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 105.04%INSIDERS 2.96%OTHER / RETAIL 0.00%851 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Blackrock Inc. | 8.61% | 5.6M | $1.43B | +2.6% |
| Vanguard Portfolio Management LLC | 4.60% | 3.0M | $765.4M | NEW |
| Capital World Investors | 4.12% | 2.7M | $685.9M | +0.3% |
| Vanguard Capital Management LLC | 4.08% | 2.6M | $679.5M | NEW |
| FMR, LLC | 3.51% | 2.3M | $583.9M | +184.1% |
| LSV Asset Management | 3.50% | 2.3M | $583.7M | -4.7% |
| Franklin Resources, Inc. | 3.02% | 2.0M | $502.6M | +7.7% |
| Dimensional Fund Advisors LP | 2.92% | 1.9M | $486.2M | -27.8% |
| State Street Corporation | 2.91% | 1.9M | $485.3M | +2.9% |
| EcoR1 Capital, LLC | 2.63% | 1.7M | $437.8M | +0.0% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.